Rivernorth Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49,678
Closed -$2.98K 570
2023
Q3
$2.98K Hold
49,678
﹤0.01% 474
2023
Q2
$6.46K Buy
+49,678
New +$5.14K ﹤0.01% 449

Rivernorth Capital Management's BIOSW Position: Q4 2023 in Review

Rivernorth Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 49,678 shares — an estimated $2.98K sold.

Rivernorth Capital Management first reported a position in BIOSW in Q2 2023 and held it in 2 quarters. The position peaked at $6.46K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Rivernorth Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Rivernorth Capital Management sold 49,678 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $2.98K.
  • Rivernorth Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2023 and held it in 2 quarters.
  • Rivernorth Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $6.46K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Rivernorth Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.